To protect itself against disease, the human body has immune cells that patrol like police officers, entering disease cells and destroying them. But some dangerous cells, including some solid tumors, ...
This collaboration aims to support and accelerate clinical development of advanced and novel technologies. Aurigene Pharmaceutical Services, an India-based contract research, development, and ...
Dr Reddy’s Laboratories Inc, a wholly-owned subsidiary of Dr Reddy’s Laboratories, has acquired a 6.5% stake in Edity, an Israeli biotech company. The acquisition was made for $2 million in cash.
Dr. Reddy’s Laboratories has acquired 6.46 per cent of the shareholding of Edity Therapeutics Ltd, an Israel-based development stage biotechnology company. As part of the acquisition, Hyderabad-based ...